He Yousheng’s New Logo
A Fresh Start, A New Beginning | Hycells’s Brand Identity Fully Reimagined
Release Date:
2026-06-09 15:35
Every step forward is aimed at fulfilling our mission even more effectively.
Hycells Bio officially announces a comprehensive brand refresh: a new logo, a revamped official website, and an updated visual identity system, all effective immediately.
This marks not only a visual refresh but also a significant milestone in Hycells’s ongoing commitment to deepening its expertise in primary cell and biopharmaceutical services, as it moves toward greater professionalism and internationalization.
New Logo · New Meaning
The new logo carries forward Hycells’s brand DNA of “Collaboration, Care, and Renewal,” employing a more contemporary visual language to convey our reverence for and unwavering commitment to the life sciences.
Graphic Design: Combining the dual motifs of “cellular connectivity” and “bonds of life,” it symbolizes the precise alignment between immune cells and the tumor model.
Color scheme: Centered around “Tech Blue” and “Life Green,” symbolizing scientific rigor and vibrant vitality, respectively.
Font Upgrade: A cleaner, more internationally styled sans-serif typeface that conveys a brand image of professionalism, reliability, and trustworthiness.
The new logo has been officially launched, and the previous version will be phased out across all online and offline channels.
He Yousheng’s Old Logo
New Official Website · New Experience
The brand-new official website, launched simultaneously, has undergone a comprehensive overhaul—from its content architecture to its visual experience:
- A clearer business structure: Centered on a three‑part business closed loop—“Sample Services – Specialty Products – Technology Service Platform”—the platform has expanded into additional sections such as the Resource Center and News & Updates.
- More convenient resource downloads: product manuals, lab‑procedure videos, and experimental data summaries—available with a single click.
- A smoother interactive experience: Company colleagues’ business cards link directly to the official website, optimized for both desktop and mobile, so you can stay up to date with He Yousheng’s latest news anytime, anywhere.
Welcome to our new official website: www.hys-bio.com
New VI · New Standards
Along with the brand upgrade, Hycells Bio has simultaneously updated its comprehensive Visual Identity (VI) system, which includes:
- Office supplies (business cards, letterhead, PPT templates)
- Experimental Report and Data Presentation Template
- Exhibition Image and Promotional Materials
- Product Packaging and Labeling System
In the future, with every interaction you have with Hycells, you will experience a brand that is unified, professional, and clear. While our visual identity evolves, our original mission remains unchanged. What stays constant is Hycells’s unwavering commitment to product and service excellence.
Hycells Bio has consistently focused on the development of primary cell‑related products and services, striving to provide domestically developed tools and technological support for biopharmaceutical R&D and manufacturing.
List of Contact Persons for He Yousheng
To provide more efficient and precise services, Hycells Bio has clearly defined the roles and responsibilities of its business inquiry channels. Please feel free to contact us:
Scan the QR code below to obtain the business cards of the sales managers for each region.
Yu Maoqian in the Shanghai area
Qiu Xintian, South China Region
Gai Guangyang in North China
Li Longhui from Zhejiang and Wuhan regions
Shu Haiyan in the Nanjing area
Du Wangcheng of the Suzhou Region
He Chunlong from the Southwest Region
You may contact the relevant representative through your existing channels or via our official website at www.hys-bio.com, and we will promptly assist you.
Special Note:
This brand upgrade pertains solely to the visual identity; the company’s legal entity, corporate structure, bank accounts, and other related information remain unchanged. During the transition period, both the old and new logos may coexist. Should you have any questions, please feel free to contact the Hycells Bio team at your convenience.
Related News
With the rapid advancement of cell and gene therapies, the industry is placing increasingly stringent demands on the performance, batch-to-batch consistency, and supply-chain reliability of cell-sorting reagents. At present, the domestic market for sorting magnetic beads remains dominated by imported brands, and their high cost of use and uncertain supply have become significant barriers to both research and industrialization in China.
Recently, Professor Huang He’s team at Zhejiang University published in the top oncology journal “…”. Nature Cancer 》published a research paper titled “Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacy.” This study is the first to reveal that Serum iron overload By elucidating the key mechanisms by which ferroptosis induces functional exhaustion of CAR‑T cells, we have proposed a targeted approach. ACSL4 Alternatively, a novel strategy involves using the ferroptosis inhibitor Fer-1 to enhance CAR-T cell persistence and antitumor efficacy.
Hycells’s Selected PBMC Reconstruction Data Presentation (Part 2)
HuPBMC model Due to its rapid establishment (3–4 weeks) and ease of use, it has been widely employed for in vivo efficacy evaluation in tumor immunotherapy. However, the conventional model suffers from a critical limitation: the randomness and uncertainty inherent in donor selection. The root of the problem lies not in the model itself, but in the “seed” cells—PBMCs—introduced into the system.
Hycells’s Selected PBMC Reconstruction Data Presentation (Part 1)
The humanized PBMC-CDX model is an essential tool for in vivo efficacy evaluation of tumor immunotherapy agents. However, significant inter‑donor variability exists in the engraftment efficiency, T‑cell subset differentiation, and the risk of graft‑versus‑host disease (GVHD) among different PBMC donors, which directly impacts model stability and the experimental window.
A Fresh Start, A New Beginning | Hycells’s Brand Identity Fully Reimagined
Every step forward is aimed at fulfilling our mission even more effectively.
Focused on peptide immunogenicity assessment, precisely empowering tumor neoantigens.
In the field of cancer immunotherapy, tumor neoantigen–specific T-cell responses serve as a key metric for assessing peptide immunogenicity. Leveraging its well-established in vitro assay platform, Hycells Biotechnology offers end-to-end services—ranging from initial screening of peptide immunogenicity and antigen‑specific T-cell expansion to validation of tumor cell‑killing activity—thereby supporting the efficient and reliable discovery and validation of neoantigens.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board